New contrast agents and technologies for myocardial contrast echocardiography

New contrast agents and technologies for myocardial contrast echocardiography.

Myocardial contrast echocardiography is a new method for evaluating myocardial perfusion. However, it relies on the marriage of two evolving technologies; ultrasound contrast agents and ultrasound imaging instrumentation. To date, these technologies have only been available to a limited number of researchers throughout the world. Within the next 12 months, both agents and specialised ultrasound...

Myocardial contrast echocardiography.

MCE has evolved from a laboratory tool to a clinical procedure. It would be wrong to consider it merely another tool for imaging of myocardial perfusion. As discussed, it allows physicians to bring physiology and pathophysiology to the bedside, providing a better understanding of the underlying mechanisms of abnormal findings in individual patients. MCE can provide quantitative measurements tha...

3D Myocardial Contrast Echocardiography

Contrast echocardiography in myocardial infarction

The contrast agents used in ultrasound are approved for several clinical situations. New echocardiographic techniques, such as harmonic imaging and power pulse inversion imaging, can improve the visualization of microbubbles. In this article we discuss the early development of contrast echocardiography, new technologies that help improve image acquisition and its practical role in the assessmen...

Stress echocardiography and myocardial contrast echocardiography in viability assessment.

[1] Packer M. The neurohumoral hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 1992; 20: 248-54. [2] Andrews R, Charlesworth A, Evans A, Cowley AJ. A doubleblind, cross-over comparison of the effects of a loop diuretic and a dopamine receptor agonist as first line therapy in patients with mild congestive heart failure. Eur Heart J 1997; 1...